articleJournal of the American Society of NephrologyAug 1, 2004Closed access

Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

Colorado Kidney Care · Amgen (United States) · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Mortality rates in ESRD are unacceptably high. Disorders of mineral metabolism (hyperphosphatemia, hypercalcemia, and secondary hyperparathyroidism) are potentially modifiable. For determining associations among disorders of mineral metabolism, mortality, and morbidity in hemodialysis patients, data on 40,538 hemodialysis patients with at least one determination of serum phosphorus and calcium during the last 3 mo of 1997 were analyzed. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum phosphorus, calcium, calcium x phosphorus product, and intact parathyroid hormone (PTH) using proportional hazards regression. Also determined was whether…

No related works found for this paper.